synmedchem.com

What It Is

SYNthesis med chem is a chemistry-focused contract research organization (CRO) serving academic research institutions, biotech companies, and pharma companies. It is not positioned as a SaaS or enterprise software product, but as an outsourced small-molecule drug discovery service provider, covering project stages from hit discovery, hit-to-lead, and lead optimization to clinical candidate nomination. The company was acquired by Viva Biotech in 2021, enabling it to combine capabilities in structural biology, protein science, biological assays, DMPK, and more.

Core Capabilities

The website highlights its “Best of Both Worlds” approach: combining a global team of medicinal chemistry experts with synthetic chemistry laboratories in China. Its service modules include medicinal chemistry, custom synthesis, integrated drug discovery, PROTACs and molecular glues, ADC linker/payload synthesis, Hit Discovery, protein production, and structural biology. In medicinal chemistry, it offers SAR, synthetic route design, analytical purification, project management, and regulatory support. Custom synthesis supports complex organic synthesis, multi-step synthesis, scale-up production, and NMR/HPLC/MS analysis.

Pricing and Delivery

Its business model is based on customized services. The text explicitly mentions collaboration on a fee-for-service or FTE basis, but it does not publish packages, pricing tables, or free trials. At the project level, a Dedicated Project/Study Leader is assigned as the communication point, making it suitable for R&D teams that need ongoing outsourced chemistry resources.

Pros and Cons

Its strengths are its broad service coverage and the detailed descriptions of its capabilities in emerging modalities such as PROTACs, molecular glues, ADCs, peptides, and nucleotides. Viva Biotech’s platform also strengthens its integrated drug discovery capabilities. The drawbacks are that the publicly available information is somewhat marketing-oriented and lacks details on pricing, delivery SLAs, quality system certifications, data security, and IP protection. It is also not a software product, so there is no information on APIs, permission management, third-party software integrations, or cloud/self-hosted deployment.

Who It’s For and Access in China

It is better suited to virtual biotech companies, small and mid-sized biotech firms with limited internal chemistry capabilities, and drug discovery teams that need custom synthesis or outsourced medicinal chemistry services. The text does not specify accessibility from China, so site availability would need to be tested directly.